comparemela.com

Latest Breaking News On - Laboratories daily - Page 9 : comparemela.com

Zacks Research Weighs in on Dr Reddy s Laboratories Limited s Q3 2025 Earnings (NYSE:RDY)

Zacks Research Weighs in on Dr Reddy s Laboratories Limited s Q3 2025 Earnings (NYSE:RDY)
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

Contrasting Rubicon Organics (OTCMKTS:ROMJF) and Dr Reddy s Laboratories (NYSE:RDY)

Dr. Reddy’s Laboratories (NYSE:RDY – Get Free Report) and Rubicon Organics (OTCMKTS:ROMJF – Get Free Report) are both medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their dividends, analyst recommendations, institutional ownership, valuation, earnings, profitability and risk. Analyst Recommendations This is a summary of […]

Dr Reddy s Laboratories Limited (NYSE:RDY) Short Interest Down 23 5% in July

Dr. Reddy’s Laboratories Limited (NYSE:RDY – Get Free Report) was the recipient of a significant drop in short interest in July. As of July 15th, there was short interest totalling 1,370,000 shares, a drop of 23.5% from the June 30th total of 1,790,000 shares. Based on an average daily trading volume, of 230,800 shares, the […]

Dr Reddy s Laboratories Limited (NYSE:RDY) Sees Significant Decrease in Short Interest

Dr. Reddy’s Laboratories Limited (NYSE:RDY – Get Free Report) was the recipient of a large decline in short interest in the month of July. As of July 15th, there was short interest totalling 1,370,000 shares, a decline of 23.5% from the June 30th total of 1,790,000 shares. Approximately 0.8% of the company’s shares are short […]

Analysts Offer Predictions for Dr Reddy s Laboratories Limited s Q3 2024 Earnings (NYSE:RDY)

Dr. Reddy’s Laboratories Limited (NYSE:RDY – Free Report) – Equities research analysts at Zacks Research lifted their Q3 2024 earnings per share (EPS) estimates for shares of Dr. Reddy’s Laboratories in a research report issued on Tuesday, July 25th. Zacks Research analyst E. Bagri now expects that the company will earn $0.77 per share for […]

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.